Mounjaro (tirzepatide) is one of the most effective diabetes and weight loss medications on the market. But at over $1,000 per month without insurance, the real question is not whether it works. The question is whether Anthem will pay for it.
Anthem Blue Cross Blue Shield covers Mounjaro in most commercial plans at Tier 2, but prior authorization is required across every plan type. Step therapy rules, BMI criteria, and diagnosis requirements all affect approval. Coverage for Type 2 diabetes is more accessible than coverage for weight loss, where rules are tighter and approval is harder.
This guide walks through exactly how Anthem covers Mounjaro, what the approval process looks like, how much it costs with and without coverage, and what to do if Anthem says no.
What Is Mounjaro?
Mounjaro is a brand-name prescription medication manufactured by Eli Lilly and FDA-approved to lower blood sugar in adults with Type 2 diabetes. Its active ingredient is tirzepatide, a dual GIP and GLP-1 receptor agonist. Mounjaro is injected once weekly in doses ranging from 2.5 mg to 15 mg.
Tirzepatide targets two hormone receptors simultaneously. GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors both regulate insulin release. Dual activation produces stronger blood sugar control than single-receptor drugs like Ozempic.
Clinical trials show average weight loss of 20.9% of body weight when Mounjaro is combined with diet and exercise. Why does that matter? For insurance purposes, Mounjaro’s primary FDA approval is for diabetes, not weight loss. That distinction changes everything about how Anthem covers it.
What Is Mounjaro Approved to Treat?
Mounjaro holds FDA approval specifically for treating Type 2 diabetes in adults, not as a standalone weight loss drug under the Mounjaro brand name. The FDA approved Mounjaro for diabetes in May 2022. Tirzepatide received a separate FDA approval for weight management in November 2023 under the brand name Zepbound.
Insurance plans treat these two approvals very differently. Mounjaro for diabetes follows diabetes medication coverage rules. Zepbound for weight loss follows obesity medication rules. A patient prescribed Mounjaro off-label for weight loss faces the strictest coverage standards and the highest denial rate.
Mounjaro vs. Zepbound:
| Feature | Mounjaro | Zepbound |
| Active Ingredient | Tirzepatide | Tirzepatide |
| FDA Approval | Type 2 Diabetes (2022) | Weight Management (2023) |
| Coverage Path | Diabetes formulary | Weight loss formulary |
| Anthem Tier | Tier 2 (most plans) | Varies by plan |
| Prior Auth Required | Yes | Yes |
How Does Anthem Drug Coverage Work?
Anthem Blue Cross Blue Shield uses a tiered drug formulary to determine how much members pay for prescriptions, including Mounjaro, with each tier carrying a different copay or coinsurance level. Tier 1 covers generic drugs at the lowest cost. Tier 2 covers preferred brand-name drugs at moderate cost. Tier 3 and above carry higher out-of-pocket costs.
Most Anthem commercial plans place Mounjaro at Tier 2 with prior authorization required. Tier 2 cost-sharing kicks in after the annual deductible is met. The deductible, copay, and coinsurance all vary by the specific plan chosen through an employer or marketplace.
But here is what most people miss: tier placement and prior authorization are separate gates. A drug can be on the formulary at Tier 2 and still be denied if the prior authorization criteria are not met. Both must be cleared before Anthem pays a single dollar toward Mounjaro.
What Is a Drug Formulary?
A drug formulary is a master list of prescription medications covered by an insurance plan, organized into tiers that determine the member’s share of the cost. Anthem updates its formulary periodically. A drug on Tier 2 in 2024 could move to Tier 3 or get excluded entirely in 2025. Members should verify Mounjaro’s formulary status each year during open enrollment.
Formulary notes contain more than just tier placement. Quantity limits, step therapy requirements, and prior authorization criteria all appear alongside the tier designation. Anthem’s online member portal includes a drug list search where members can look up Mounjaro by plan to see all restrictions that apply.
Key Formulary Terms to Know:
- Prior Authorization: Insurance approval required before the pharmacy can fill the prescription
- Step Therapy: Must try cheaper medications first before the plan covers a more expensive drug
- Quantity Limits: Anthem typically covers 1 Mounjaro pen per 28-30 days
- Tier Placement: Mounjaro is typically Tier 2 (preferred brand) on Anthem commercial plans
- Non-Preferred Status: If moved to Tier 3, copays increase significantly
Does Anthem Cover Mounjaro?
Anthem Blue Cross Blue Shield covers Mounjaro in most commercial plans, listing it as a Tier 2 preferred brand drug with prior authorization and quantity limits of one injection pen per 28 to 30 days. Coverage rates for GLP-1 medications like Mounjaro range from 60% to 80% across major insurers. Anthem BCBS plans in multiple states confirm Mounjaro at Tier 2 with prior authorization required.
Coverage varies significantly by plan type. Employer-sponsored PPO and HMO plans generally include Mounjaro on the formulary. Health Exchange plans may carry different tier placements. Medicare Advantage Part D plans follow CMS guidelines and may differ from commercial plans. Medicaid coverage depends on the state and the specific managed Medicaid program.
Here is the kicker: a board-certified physician specializing in weight loss notes that insurance companies are becoming less likely to cover GLP-1 medications like Mounjaro due to cost. Members without a Type 2 diabetes diagnosis or who do not meet BMI criteria face harder approval standards in 2025 and 2026 than in prior years.
Does Anthem Cover Mounjaro for Type 2 Diabetes?
Anthem covers Mounjaro for Type 2 diabetes when the prescribing provider documents medical necessity and the member meets prior authorization criteria including diagnosis, A1C levels, and medication history. This is the most straightforward coverage path. Approval rates for diabetes-indicated requests are higher than for weight loss requests.
Step therapy requirements still apply. Anthem’s clinical utilization management guidelines require that a patient try metformin or another first-line agent before Mounjaro qualifies for approval. Does that mean everyone gets denied on the first try? Not if the provider submits complete documentation of prior drug trials alongside the PA request.
Does Anthem Cover Mounjaro for Weight Loss?
Anthem does not typically cover Mounjaro for weight loss, because weight loss is considered an off-label use of the Mounjaro brand, which holds FDA approval only for Type 2 diabetes. Tirzepatide for weight loss is covered under the Zepbound brand name on some Anthem PPO plans with prior authorization and documented medical necessity.
Eligible Anthem PPO members can access weight loss care through in-network providers. Some Anthem plans cover Wegovy or Zepbound with proof of obesity-related medical conditions. If medications are not covered directly, some in-network providers offer tirzepatide through compounding pharmacies at lower cost, though compounded versions are not FDA-approved.
What Does Anthem Require to Approve Mounjaro?
Anthem requires prior authorization for Mounjaro across all commercial plan types, meaning the prescribing doctor must submit clinical documentation before any pharmacy can fill the prescription at the covered rate. The request must include the patient’s diabetes diagnosis code, most recent A1C level, body weight, BMI, and a medication history listing all prior diabetes treatments.
Missing documentation is the most common reason for delays. Anthem will not process an incomplete PA request. Providers who submit all required clinical information upfront avoid restart delays and get faster decisions.
Anthem Mounjaro Prior Authorization Requirements:
| Requirement | What to Submit | Where to Find It |
| Diagnosis | Type 2 diabetes ICD-10 code | Doctor’s chart |
| A1C Level | Recent lab result | Lab report |
| BMI | Current weight and height | Doctor’s office |
| Step Therapy | Prior medications tried and failed | Medication history |
| PA Form | Anthem fax form | Anthem drug list portal |
What Is Step Therapy for Mounjaro?
Step therapy for Mounjaro is Anthem’s requirement that a patient first try one or more less expensive diabetes medications before the plan will approve coverage for Mounjaro. The typical first step is metformin, the standard first-line Type 2 diabetes treatment. A second step may involve a sulfonylurea or another oral agent. Documentation of these steps must accompany the PA request.
Step therapy exceptions do exist. A provider can request an exception when a patient has a documented contraindication to first-line drugs, has already tried them without achieving adequate blood sugar control, or has a clinical reason why step therapy is inappropriate. The exception requires written documentation submitted through the same PA channel as the initial request.
How Do You Get Prior Authorization for Mounjaro?
Prior authorization for Mounjaro begins with the prescribing doctor submitting a completed PA request to Anthem through the provider portal, by fax using Anthem’s PA fax form, or by phone to Anthem’s prior authorization department. Standard requests are processed within 1 to 3 business days. Urgent requests receive a decision within 24 to 72 hours, provided complete documentation is submitted.
Members can track PA status through the Anthem member portal or by calling Member Services. Approved PA authorizations are typically valid for one year before renewal. A denial comes with a written explanation identifying the specific reason, which forms the basis for any appeal filed by the member or provider.
How Much Does Mounjaro Cost With Anthem?
Mounjaro costs approximately $1,069 per month at retail without insurance. With Anthem Tier 2 coverage, members pay a copay or coinsurance after their annual deductible is met, reducing the monthly cost substantially compared to paying out of pocket. Employer-sponsored plans typically carry lower cost-sharing than marketplace plans for brand-name drugs on Tier 2.
Eli Lilly offers a Mounjaro Copay Card for commercially insured patients. The card reduces out-of-pocket costs further for members who already have Anthem coverage. This is important: the Mounjaro Copay Card does not apply to Medicare, Medicaid, or TRICARE members. Government-insured patients cannot stack the copay card on top of plan benefits.
Ready to lower your monthly costs? Get a proven weight loss plan built around these exact principles and start saving on your medication journey.
How Much Does Mounjaro Cost Without Anthem Coverage?
Without insurance, Mounjaro costs between $1,000 and $1,069 per month at retail pharmacies. Eli Lilly’s Lilly Cares Foundation patient assistance program currently does not cover Mounjaro for uninsured or government-insured patients, leaving compounding pharmacies as the main lower-cost alternative. Compounded tirzepatide is not FDA-approved and may differ in quality and consistency from the branded product.
Discount programs like SingleCare and GoodRx list Mounjaro prices but rarely reduce the monthly cost below several hundred dollars. Members denied by Anthem face a real choice: pay full price, pursue an appeal, or work with a provider to find an alternative diabetes medication covered at a lower tier.
What Happens If Anthem Denies Mounjaro?
If Anthem denies a Mounjaro prior authorization, the member and provider receive a written denial letter with the specific reason for rejection. The denial letter must include information about the right to appeal and the deadline for submitting the appeal, typically 60 to 90 days from the denial date. Common denial reasons include failure to meet step therapy requirements, insufficient clinical documentation, or a ‘not medically necessary’ determination.
Internal appeals ask Anthem to reconsider the denial. The provider submits additional clinical notes, a letter of medical necessity, and supporting evidence. Anthem must respond to standard internal appeals within 30 to 60 days. Urgent appeals receive a response within 72 hours. A denial upheld through internal appeal can be escalated to an external independent review.
Ohio’s external review process allows members to request review by an independent organization outside of Anthem. The external reviewer’s decision is binding on Anthem. Members in other states have similar rights under the Affordable Care Act. Specialist firms that analyze denial letters and draft evidence-backed rebuttals aligned to the plan’s own clinical criteria can dramatically improve the odds of a successful appeal.
Mounjaro Denial Appeal Steps:
- Request the written denial letter from Anthem and read the specific denial reason
- Contact the prescribing provider to gather additional clinical documentation
- Submit a formal internal appeal within the deadline (typically 60-90 days)
- Request a peer-to-peer review between the provider and Anthem’s medical director
- If internal appeal fails, file for an independent external review
How Do You Check Your Anthem Mounjaro Coverage?
The fastest way to check Anthem Mounjaro coverage is to call the Member Services number printed on the back of the insurance card and ask specifically about tirzepatide under the Mounjaro brand name. The call should confirm the formulary tier, prior authorization status, step therapy requirements, quantity limits, and the expected copay after the deductible is met. Record the representative’s name, the date of the call, and the reference number.
Anthem’s online member portal also includes a drug list search. Members who log in see the formulary specific to their plan. The search shows tier placement, PA requirements, and links to prior authorization fax forms. Checking the portal first gives a written record of the coverage details before calling.
Questions to Ask Anthem Member Services:
- What tier is Mounjaro on my specific plan?
- Is prior authorization required for Mounjaro?
- What are the step therapy requirements before Mounjaro is approved?
- What are the quantity limits per month?
- What is my copay or coinsurance after my deductible is met?
- Is Zepbound covered differently than Mounjaro on my plan?
How Long Does Mounjaro Prior Authorization Take With Anthem?
Standard Mounjaro prior authorization through Anthem takes 1 to 3 business days from the date the doctor’s office submits a complete request with all required documentation. Urgent PA requests receive a decision within 24 to 72 hours. Incomplete submissions extend the timeline. A missing A1C result, step therapy history, or diagnosis code restarts the review.
Internal appeals take longer. Standard internal appeals receive a decision within 30 to 60 days. Urgent internal appeals get a response within 72 hours. An external independent review adds additional weeks. The full cycle from initial submission to a binding external review decision can span 60 to 90 days. And here is what that means practically: start the PA process before the prescription runs out, not after.
Want Your Free Mounjaro Coverage Guide From Eat Proteins?
You have the information. Now you need the plan. Navigating Anthem’s prior authorization process, step therapy requirements, and appeal deadlines is not something most people figure out on the first try. And every week without approval is another week paying full price.
Our nutritionists at Eat Proteins built a free coverage guide that walks through the exact steps to get Mounjaro approved, what documentation to give your provider, and how to appeal a denial effectively. You should not be stuck paying over $1,000 a month for a medication your Anthem plan should cover. Get the guide, follow the steps, and stop leaving money on the table.